Other OTC - Delayed Quote USD

Elbit Imaging Ltd. (EMITF)

0.8500 0.0000 (0.00%)
As of April 15 at 10:05 AM EDT. Market Open.
Loading Chart for EMITF
DELL
  • Previous Close 0.8500
  • Open 0.8500
  • Bid --
  • Ask --
  • Day's Range 0.8500 - 0.8500
  • 52 Week Range 0.0956 - 1.2500
  • Volume 1
  • Avg. Volume 758
  • Market Cap (intraday) 9.943M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4900
  • Earnings Date --
  • Forward Dividend & Yield 0.04 (4.78%)
  • Ex-Dividend Date Jun 29, 2023
  • 1y Target Est --

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: EMITF

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EMITF
19.05%
TA-125
4.58%

1-Year Return

EMITF
1,226.83%
TA-125
14.53%

3-Year Return

EMITF
1,073.78%
TA-125
15.53%

5-Year Return

EMITF
2,119.27%
TA-125
33.48%

Compare To: EMITF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMITF

Valuation Measures

Annual
As of 4/11/2024
  • Market Cap

    9.98M

  • Enterprise Value

    -1.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    -0.60

  • Enterprise Value/EBITDA

    0.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -5.14%

  • Return on Equity (ttm)

    -28.95%

  • Revenue (ttm)

    4.41M

  • Net Income Avi to Common (ttm)

    -18.14M

  • Diluted EPS (ttm)

    -0.4900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.54M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    78k

Company Insights: EMITF

Fair Value

0.8500 Current
 

Dividend Score

0 Low
EMITF
Sector Avg.
100 High
 

Hiring Score

0 Low
EMITF
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
EMITF
Sector Avg.
100 High
 

People Also Watch